Condition
Lung Fibrosis clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Lung Fibrosis clinical trials that are recruiting, at sites in 4 countries (most in United States (2), China (1), Belgium (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Lung Fibrosis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Do airway mucus plugs cause lung scarring in people with COPD undergoing lung cancer surgery | — | Shanghai | Recruiting | Nov 19, 2025 |
| Home-based pulmonary rehabilitation and health coaching for lung fibrosis patients | — | Scottsdale, Arizona and 3 other locations | Recruiting | Dec 27, 2024 |
| Evaluating FAP as a biomarker for fibrotic lung diseases | Phase 2 | Brussels | Recruiting | Jan 5, 2024 |
| Registry for individuals affected by pulmonary fibrosis | — | Chicago, Illinois | Recruiting | May 19, 2022 |
| Using exosomes to modulate the immune response in critically ill COVID-19 patients | — | Ulm | Recruiting | Jan 13, 2022 |
All recruiting trials (5)
-
Do airway mucus plugs cause lung scarring in people with COPD undergoing lung cancer surgery
This study will see if airway mucus plugs in people with COPD are linked to lung scarring by analyzing lung tissue and mucus collected during lung cancer operations.
-
Home-based pulmonary rehabilitation and health coaching for lung fibrosis patients
This study tests whether a home-based rehab program with health coaching can help people with lung fibrosis feel better and be more active compared to regular care.
-
Evaluating FAP as a biomarker for fibrotic lung diseases
This study is testing if a protein called FAP can help doctors understand and track fibrotic lung diseases like idiopathic pulmonary fibrosis by looking at its levels in different samples and using special scans before and after treatments.
-
Registry for individuals affected by pulmonary fibrosis
This study invites people with pulmonary fibrosis, along with their caregivers and family members, to share their experiences through online surveys to help researchers understand the condition better and possibly reach out for future studies.
-
Using exosomes to modulate the immune response in critically ill COVID-19 patients
This study is testing whether exosomes from stem cells can help improve the immune response and reduce inflammation in critically ill COVID-19 patients.
Related topics
Quick answers
How many Lung Fibrosis clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), China (1 trial), Belgium (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.